| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,475 | 18,922 | 17,317 | 18,113 | | Cost of Revenue | 10,034 | 10,378 | 11,374 | 10,824 | | | Gross Profit | 6,441 | 8,544 | 5,943 | 7,289 | | | Operating Expenses | | Research Development | 160 | 77 | 154 | 256 | | Selling General and Administrative | 8,000 | 8,876 | 8,254 | 6,831 | | Non Recurring | (781) |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (938) | (409) | (2,465) | 202 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | (31) | (108) | 59 | | Earnings Before Interest And Taxes | (935) | (440) | (2,573) | 261 | | Interest Expense | 27 | 26 | 30 | 42 | | Income Before Tax | (962) | (466) | (2,603) | 219 | | Income Tax Expense | (264) | (188) | (1,041) | 799 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (698) | (278) | (1,562) | (580) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (698) | (278) | (1,562) | (580) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($698) | ($278) | ($1,562) | ($580) |
|
0.03% Nasdaq 0.00%
Income Statement
